Board of Directors

Mark Bleyer, President, Cook Biotech, Inc.

David Johnson, CEO, BioCrossroads

Anthony Hubbard, Bioscience Vaccines, Inc.

Amy Overby, Bioscience Vaccines, Inc.

Scientific Advisory Board

Darron R. Brown, M.D., Professor of Medicine, Microbiology, and Immunology, Indiana University School of Medicine

Neal Fearnot, Ph.D., Vice President, Cook Group, Inc.

Harm HogenEsch, DVM, Ph.D., Associate Dean for Research School of Veterinary Medicine, Purdue University

Suresh Mittal, DVM, MS, Ph.D., Professor of Comparative Pathobiology, Purdue University

Timothy Ratliff, Ph.D., Director of Purdue Cancer Center, Purdue University

Anthony J. Hubbard, Executive Vice President and CFO. Mr. Hubbard has provided executive, financial, and accounting services to founding management teams. He has served in an executive capacity as the Vice President of Finance, Chief Financial Officer, and General Manager for these companies. Prior to his most recent assignment, he managed business development as a general partner in a small business-consulting firm and served as a CFO of an emerging biotechnology venture from 1999 to 2002. He was a partner in a CPA firm that provided business, management and tax advisory services to entrepreneurial enterprises. Prior to joining a CPA firm in Indianapolis he co-founded and held the position of CEO for a biotechnology company for six years. He has served on the Board of Directors of a medical device industry trade association and various community groups. Mr. Hubbard is a licensed CPA and has earned a B.A. degree in Microbiology and Biological Sciences, as well as a MBA in Finance from Indiana University Kelly School of Business.

Mark A. Suckow, D.V.M., Chief Scientific Officer. Mark A. Suckow is Director of the Freimann Life Science Center and Associate Research Professor of Biological Sciences at the University of Notre Dame in Notre Dame, IN. Dr. Suckow earned the degree of Doctor of Veterinary Medicine from the University of Wisconsin in 1987, and completed a post-doctoral residency program in laboratory animal medicine at the University of Michigan in 1990. He is a Diplomate of the American College of Laboratory Animal Medicine (ACLAM). Dr. Suckow has published over 80 scientific papers, books, and book chapters. In addition, he co-edited The IACUC Handbook (CRC Press, 2000 and 2007) and The Laboratory Rat (Elsevier Academic Press, 2006). Dr. Suckow’s research focuses on cancer vaccines and vaccine adjuvants, and he has extensive experience with rodent models of cancer. Dr. Suckow served as 2006 President of the American Association for Laboratory Animal Science (AALAS) and is currently on the Board of Directors of the American Society of Laboratory Animal Practitioners (ASLAP). He was honored as the 1996 Young Investigator of the Year by the American Association for Laboratory Animal Science, and in 1998 he received the Excellence in Research Award from the American Society of Laboratory Animal Practitioners.

Amy M. Overby, Vice President of Operations. Mrs. Overby has over 15 years of experience in the medical and research fields. Mrs. Overby received her B.S. degree in molecular biology, biochemistry, and bioinformatics from Towson University and worked in cancer cytogenetics at The Johns Hopkins University School of Medicine prior to joining the research department at Cook Biotech, Inc. in 2005. At Cook Biotech, Inc. she was the principal scientist for novel ECM based technologies from research/development phases to manufacturing transfer, including initiating and implementing extensive in vitro and in vivo studies within industries and universities. She managed undergraduate students, interns, medical students and support staff with experimental techniques and laboratory protocols/procedures as well as establishing and maintaining Biosafety Level 2 (BL2) laboratories. She has multiple peer-reviewed articles and patents pending

Rae D. Record Ritchie, Ph.D., Vice President of Research. Dr. Ritchie has more than 25 years experience in clinical and research laboratories. She has been the lead investigator on grants and research contracts and her research has resulted in over 25 peer-reviewed articles. Her administrative experience includes establishing and maintaining a genetic tissue bank, managing a multi-user facility, and overseeing testing agreements. Dr. Ritchie has supervised technicians as well as mentored and assisted high school students, undergraduate, graduate, medical students and post-doctoral fellows. Dr. Ritchie has over 10 years experience working with the base material comprising the ECM Adjuvant resulting in one patent and numerous publications. She has been a member of an external advisory committee for an NIH sponsored program at the University of Puerto Rico and a consultant for biotech firms. Dr. Ritchie received her B.S degree from Purdue University in Biomedical Technology and her Ph.D. from Texas A&M University in Biology.